📰 Response Algorithm News
Response Algorithm News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Response Algorithm. Real-time updates on events, politics, business and more.
April 5, 2024
The precision oncology medicine company guided three drugs in the trial pipeline with uncommon efficiency.
January 18, 2022
/PRNewswire/ -- Lantern Pharma (NASDAQ: LTRN), a clinical stage biopharmaceutical company using its proprietary RADR® artificial intelligence ("A.I.") platform...
January 18, 2022
They will use expanded mutational signature analyses to identify new biomarker-defined indications in multiple tumor types.
January 12, 2022
/PRNewswire/ -- Lantern Pharma (NASDAQ: LTRN), a clinical stage biopharmaceutical company using its proprietary RADR® artificial intelligence ("A.I.") platform...
January 4, 2022
/PRNewswire/ -- Lantern Pharma (NASDAQ: LTRN), a clinical stage biopharmaceutical company using its proprietary RADR® artificial intelligence ("A.I.") platform...